In a January 21 memorandum, President Obama directed the Chief Technology Officer to coordinate the development of an Open Government Directive that would implement the Administration’s principles of transparency.
But there is no Chief Technology Officer (CTO), so far.
And there are fundamental questions about the nature, role, authority, budget, and status of such a position that remain to be answered. Many of the uncertainties involved are usefully delineated in a new report (pdf) from the Congressional Research Service.
Up to now, the CRS report said, it is unknown “where a CTO would be located organizationally; whether a CTO would be a single position or supported by a staff, office, or agency; and how the duties and authorities of a CTO would be aligned and integrated with existing offices and agencies charged with similar responsibilities.”
Further, “The President has not indicated whether he intends to establish a CTO position by executive order or other administrative process, or whether he will seek legislation.”
Even more fundamentally, “What would be the scope of duties and authorities given to this position?”
Finally, the CRS astutely observed, “while the duties envisioned for a CTO may affect President Obama’s choice for the [position], the attributes of the person appointed to serve as CTO may, in part, define the role of CTO.”
See “A Federal Chief Technology Officer in the Obama Administration: Options and Issues for Consideration,” January 21, 2009.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.